Abstract: This invention presents a sulphurous acid generator which employs a combination of novel blending contact and mixing mechanisms which maximize the efficiency and duration of contact between sulphur dioxide gas and water to form sulphurous acid in an open nonpressurized system, without employing a countercurrent absorption tower.

Abstract: A catalyzer for burning part of a gaseous fuel/oxidant mixture, in particular for a burner of a power plant installation, has catalytically active channels and catalytically inactive channels and at least two sectors are arranged consecutively in the main flow direction. The sectors include a first sector defining an inlet sector and at least one following sector that includes one or more of a mixing sector arranged downstream from the inlet sector and an outlet sector. Further, the catalyzer has one or more of a smaller flow resistance in the inlet sector than any following sector, a higher catalytic activity in the inlet sector than any following sector, a plurality of holes in the mixing sector oriented transversely to the main flow direction and through which adjoining channels communicate, and a swirl generator in the outlet sector that provides a swirl to a gas mixture flowing through the outlet sector.

Abstract: A cylindrical steam reforming unit contains a plurality of cylindrical bodies consisting of a first cylindrical body, a second cylindrical body and a third cylindrical body of successively increasing diameters disposed in concentric spaced relationship, a radiation cylinder disposed within and concentrically with the first cylindrical body, a burner disposed in the radial central portion of the radiation cylinder, and a reforming catalyst layer with a reforming catalyst filled in a gap between the first and second cylindrical bodies, wherein a CO shift catalyst layer and a CO removal catalyst layer are disposed in a gap between the second and third cylindrical bodies, the CO shift catalyst layer being formed in a gap with the direction of flow reversing at one axial end of the reforming catalyst layer and through a heat recovery layer of predetermined length.

Abstract: For mixing and distributing a gas phase and a liquid phase over a granular bed, employing an annular peripheral zone inside a reactor via which liquid is introduced and which acts as a buffer zone against fluctuations in the flow of the liquid phase. The device is applicable to catalytic bed chemical reactors especially for the hydrotreatment of hydrocarbons.

Abstract: A device has a reaction chamber with at least one feed inlet (5) and at least one evacuation outlet (10). An outside jacket (2a) that is resistant to internal pressure is positioned around the device and contains at least one module (44) through which a reagent and formed products circulate. The module (44) has walls (11) and (12) made of refractory material that are included in a sealed jacket (40). The sealed jacket (40) is connected by a flexible connection to the jacket (2a) and to a heat exchanger that is also linked to the module (44) and to the jacket (2a) by a flexible connection.

Abstract: An improved method and apparatus is set forth for packaging substrates in a monolith reactor, wherein the substrates are positioned in a stacked relationship along a longitudinal axis of the reactor housing. The stack of substrates is supported in a fixed position at the bottom of the stack, and the upper end of the stack is provided with a predetermined constant compression to not only compensate for different expansions between the stacked substrates and the reactor housing, but also to hold the stacked assemblies together in a tight relationship so as to prevent deleterious vibration of the substrates. The compression is preferably applied by spring-loaded means, which may be adjusted by threading a nut against the loading spring.

Abstract: A method for the dissolution and purification of tantalum ore and synthetic concentrates is described. The method preferably uses ammonium bifluoride as the fluoride source in place of the hydrofluoric acid used in the conventional methods. Other fluoride compounds such as NaF, KF, and CaF2 may be used alone or in combination with ammonium bifluoride. The tantalum concentrate and fluoride source are combined with sulfuric acid to form a solution containing tantalum values and impurities. The tantalum values are then separated from the impurities by solvent extraction.

Abstract: A process for economically separating and recovering valuable metal components, with few kinds of chemicals being used, with no waste water that causes environmental pollution being discharged, and also perfectly no by-products being formed by means of simple steps.

Abstract: The present invention is directed to an iron-promoted zeolite beta catalyst useful in the selective catalytic reduction of nitrogen oxides with ammonia in which the iron-promoted zeolite beta is treated so as to provide increased amounts of the iron promoter in the form of Fe(OH). The stabilized zeolite is formed by cation exchange of an iron salt into a zeolite beta which has a reduced sodium content such as by exchanging a sodium beta with ammonium or hydrogen cations. A zeolite beta having a reduced carbon content and a Si/Al ratio of no more than 10 also increases the Fe(OH) content of the iron-promoted catalyst. The iron-promoted catalyst which has the iron in the form of Fe(OH) is characterized by a peak at 3680±5 cm?1 in the IR spectra.

Abstract: A tetracalcium phosphate (TTCP) particle for use in preparing a fast-setting, bioresorbable calcium phosphate cement is disclosed. The TTCP particle has a basic calcium phosphate whiskers on a surface thereof; the basic calcium phosphate whiskers having a Ca/P molar ratio greater than 1.33, and having a length up to about 5000 nm and a width up to about 500 nm. The basic calcium phosphate whiskers are substantially free of a hydroxyapatite phase and mainly composed of TTCP phase.

Abstract: A method for producing nanostructured multi-component or doped oxide particles and the particles produced therein. The process includes the steps of (i) dissolving salts of cations, which are either dopants or components of the final oxide, in an organic solvent; (ii) adding a dispersion of nanoparticles of a single component oxide to the liquid solution; (iii) heating the liquid solution to facilitate diffusion of cations into the nanoparticles; (iv) separating the solids from the liquid solution; and (v) heat treating the solids either to form the desired crystal structure in case of multi-component oxide or to render the homogeneous distribution of dopant cation in the host oxide structure. The process produces nanocrystalline multi-component or doped oxide nanoparticles with a particle size of 5–500 nm, more preferably 20–100 nm; the collection of particles have an average secondary (or aggregate) particle size is in the range of 25–2000 nm, preferably of less than 500 nm.

Abstract: A method of fabricating barium titanate powders uses titanium tetrachloride and barium hydroxide as reactants in a reaction solution. The pH value of the reaction solution is adjusted to strongly alkaline range by adding potassium hydroxide. Nitrogen is charged into a reaction tank at normal pressure, and the reaction solution is heated at 80–102°. The solution is intensively stirred at constant temperature, and then subjected to a hydro-thermal reflux. Then, the solution is treated through an ion exchange resin and dried to obtain a cubic BaTiO3 powders.

Abstract: An improved process for producing titanium dioxide by reacting a titanium dioxide ore with chlorine to produce a gaseous stream containing titanium tetrachloride, condensing titanium tetrachloride from the gaseous stream containing titanium tetrachloride to produce chlorinator tail gas, vaporizing the condensed titanium tetrachloride, reacting the vaporized titanium tetrachloride with oxygen to produce a gaseous stream containing titanium dioxide particles and chlorine, separating the titanium dioxide particles from the gaseous stream containing titanium dioxide particles and chlorine to produce burner tail gas, analyzing the chlorinator tail gas for residual chlorine to control the step of reacting the titanium dioxide ore with chlorine, analyzing the burner tail gas for oxygen to control the step of reacting the condensed titanium tetrachloride with oxygen. The improvement is to analyze the chlorinator tail gas for residual chlorine (and/or the burner tail gas for oxygen) using an on-line analyzer.

Abstract: A TS-1 catalyst suitable for the production of oxirane compounds is prepared by subjecting conventionally formed TS-1 to a size reduction treatment such as milling such that the average particle size weighted by volume of the TS-1 is reduced to less than 10 microns in diameter and the size reduced TS-1 is spray dried.

Abstract: The present invention provides a biomolecular carrier of pharmaceuticals, comprising: a biomolecule carrier bearing molecules that bind to a cellular adhesion molecule expressed on endothelial cell; and a pharmaceutical. The present invention also provides a method of treating a pathophysiological state in an individual in need of such treatment, comprising the steps of: irradiating a target tissue or organ in said individual; and administering to said individual the biomolecular carrier disclosed herein.

Abstract: The invention provides a composition of matter of formula I V-L-R ??(I) where V is an organic group having binding affinity for an angiotensin II receptor site, L is a linker moiety or a bond, and R is a moiety detectable in in vivo imaging of a human or animal body, with the provisos that where V is angiotensin or a peptidic angiotensin derivative or analog then V-L-R is other than a non-metal radionuclide substituted peptide (eg 125I substituted angiotensin II) and L-V is other than simply a peptide with a chelating agent amide bonded to a side chain thereof. This composition of matter may be used to image cardiovascular diseases and disorders.

Abstract: The present invention deals with a composition for evidencing bacterial plaque based on natural colorants comprising at least one concentrated solution of natural colorant selected from the group consisting of colorants extracted from the aai (Euterpe oleracea) and colorants extracted from urucum (Bixa orellana), in a pharmaceutically acceptable vehicle and, optionally, acceptable pharmaceutical additives. Preferentially, in the case of the aai solution, the concentration varies from 60 to 95% of concentrated extract, whilst for the urucum solution, the concentration varies between 56 and 90% of concentrated extract. Also preferentially, in solutions containing a mixture of the extracts, these will be present in a proportion that varies from 10:1 to 1:1.

Abstract: A composition for reducing dentinal hypersensitivity and remineralizing exposed dentinal surface and open dentinal tubules, comprising a non-aqueous carrier and a desensitizing amount of a desensitizing/remineralizing agent which consists essentially of a water soluble calcium salt and an incompatible ingredient which would otherwise react with the calcium salt. Upon contact with saliva when applied to an oral cavity, the desensitizing/remineralizing is then formed in situ by the reaction between the calcium salt and the incompatible ingredient, thereby remineralizing exposed dentinal surface and open dentinal tubules.

Abstract: The present invention relates to the formation of surface treated zinc oxide and titania particles, and in particular zinc oxide and titania nanoparticles, with a siloxane star-graft copolymer coating, comprising a looped and/or linear polymeric structure on a star-graft copolymer coating, on a particle surface to control the interfacial surface interactions between the particle and the oil phase of the cosmetic skin formulation.

Abstract: A hair tonic composition containing adenosine, adenosine 5?-phosphate, and/or an adenosine 5?-phosphate salt as an active ingredient.

Abstract: Novel esters prepared by the reaction of shea butter, preferably mild-processed shea butter (MPSB), and fatty alcohol. Materials of the present invention are useful as cosmetic and personal care ingredients, allowing for the delivery of highly desirable active ingredients present in shea butter, including natural antioxidants, in an oil-soluble, emollient material that is substantive to the skin and hair.

Abstract: Methods of treating an inanimate object or inanimate surface which has malodor impression to reduce the malodor impression comprise the step of contacting the inanimate object or inanimate surface with an effective amount of a composition for reducing malodor impression comprising: (a) from about 0.1% to about 1%, by weight of the composition, of perfume; (b) cyclodextrin; (c) aerosol propellant; (d) optionally, solubilizing aid; and (e) aqueous carrier. The compositions used in the methods are essentially free of any material that would soil or stain fabric. The inanimate surface treated via the present methods is preferably fabric.

Abstract: A method of immunotherapy to treat cancer or a synergistic anti-cancer treatment by administering an effective amount of a natural cytokine mixture (NCM), an effective amount of cyclophosphamide (CY), or an effective amount of indomethacin (INDO), wherein the NCM, CY, or INDO are administered singly or in combinations thereof. An anti-metastatic treatment method by promoting differentiation and maturation of immature dendritic cells in a lymph node; allowing presentation thereof; and preventing development of metastasis. A method of using an NCM as a diagnostic skin test for predicting treatment outcome. A method of pre-treating dendritic cells (DC) and a method of treating monocyte defects characterized by sinus histiocytosis or a negative NCM skin test. Compositions and methods for eliciting an immune response to endogenous or exogenous tumor antigens.

Abstract: A method and a system is disclosed for the modulation of various characteristics of probiotic cells and for the production of probiotics having altered characteristics. Such altered characteristics include increased resistance to various stresses, drugs and chemical agents, as well as aggregation. Such a method and a system are useful for the production of probiotics with altered characteristics, which may for example provide health benefits when present in the gastrointestinal tract of an animal.

Abstract: This invention provides a method of increasing the volume of distribution of a nucleic acid encoding a therapeutic agent in a tissue in a subject during localized delivery, comprising administering to the tissue in the subject a nucleic acid encoding a therapeutic agent and a facilitating agent, whereby the inclusion of the facilitating agent increases the volume of distribution of the nucleic acid encoding a therapeutic agent in the tissue.

Abstract: A peptide corresponding to positions 62–71 of the sequence of human C-reactive protein (CRP) of the formula: Glu62-Ile-Leu-Ile-Phe-Trp-Ser-Lys-Asp-Ile71 and modifications thereof obtained by substitution, deletion, or addition of amino acids, amidation of the C-terminal or acylation of the N-terminal, are capable of inhibiting in vitro the enzymatic activity of human Leukocyte Elastase (hLE) and/or of human Cathepsin G (hCG) and can be used for the treatment of chronic inflammation conditions such as rheumatoid arthritis, pulmonary emphysema, cystic fibrosis, bronchitis, asthma and some acute respiratory distress syndrome.

Abstract: The present invention relates to mono clonal antibodies or fragments thereof for isolating and/or identifying neural progenitor cells. The antibodies or fragments thereof bind to an identical antigen as an antibody which is produced by the hybridoma cell lines W4A5, W8C3 and 57D2 deposited on Aug. 14, 2002, at the Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ) under the numbers DSM ACC2571, DSM ACC2570 and DSM ACC2568.

Abstract: Vaccine formulations comprising viral capsomeres are disclosed along with methods for their production. Therapeutic and prophylactic methods of use for the vaccine formulations are also disclosed.

Abstract: The present invention provides compositions and methods for the treatment of infection in a subject. More particularly, the invention provides a therapy for the treatment or prevention of mammary infections, such as bovine mastitis, comprising the topical administration to a subject of an anti-microbial agent and a phospholipid-containing skin conditioner.

Abstract: The invention concerns a composition for topical application for extemporaneous preparation, comprising ascorbic acid and a suitable support, the ascorbic acid being obtained by bringing at least one ascorbic acid precursor with the exception of its esters into contact with at least one enzyme that is capable of converting said precursor. It also concerns the use of one or more enzymes selected from L-galactono-1,4-lactone dehydrogenase, L-galactose dehydrogenase, L-sorbosone dehydrogenase, L-gulono-1,4-lactone oxidase and mixtures thereof, or of an extract comprising said enzyme, for the preparation of ascorbic acid for topical use, and a cosmetic method for treating the skin consisting of applying to the skin, either simultaneously or successively, at least one enzyme that can convert an ascorbic acid precursor into ascorbic acid, and at least one ascorbic acid precursor with the exception of its esters.

Abstract: The present invention relates to nano-sized self-assembled structured concentrates and their use as effective suitable carriers for transferring active components into the human body. The nano-sized self-assembled concentrates are composed of an aqueous phase, an oil phase, a surfactant a co-solvent and co-surfactant. The formed nano-sized self-assembled structured concentrates may be in the form of an aqueous continuous phase, an oil continuous phase or a bicontinuous phase, and may thus be diluted to any desired extent in either oil or water maintaining their structure and the active material comprised within the nano-sized self-assembled structured concentrates.

Abstract: A new vigor test is used to select seeds which, after appropriate polymeric coating, will perform well under adverse planting and growing conditions. For example, suitably coated hybrid corn seeds can be planted earlier than seeds now available, while still obtaining comparable or better yields. Particularly good results are obtained when seeds are coated with compositions comprising a side chain crystalline polymer and an amorphous polymer.

Abstract: Nitrogen containing compounds are effective as subterranean termite feeding stimulants/aggregants and as masking agents for concealing the presence of other compounds which are repellents to termites, when they are used in low concentrations, less than or equal to about 1000 ppm (0.1%, by weight). The nitrogen containing compounds may be formulated alone, or optionally in a bait or in combination with other compounds effective for controlling or marking subterranean termites.

Abstract: Methods and compositions for the prevention and treatment of all forms of atherosclerosis are described. Administration of compounds such as thalidomide, its analogs, hydrolysis products, metabolites, derivatives and precursors as well as additional compounds capable of inhibiting tumor necrosis factor ? (TNF-?) are used in the invention. Also disclosed is the coating of prosthetic devices, such as stents, with the compounds of the invention for the prevention and/or treatment of restenosis.

Abstract: Oligosaccharides produced by an alternansucrase enzyme catalyzed reaction of sucrose with an acceptor oligosaccharide are effective as prebiotics for controlling enteric bacterial pathogens. Populations of enteropathogenic bacteria may be substantially reduced or inhibited by treatment of an animal with a composition comprising one or more of these oligosaccharides in an amount effective to promote the growth of beneficial bacteria. The method is particularly effective for the control of Salmonella species, enteropathogenic Escherichia coli, and Clostridia perfringens.

Abstract: The invention comprises a transdermal dosage form comprising a active agent component comprising a polymeric matrix and an abusable drug substance, an overlay backing, a porous material, and an antagonist reservoir comprising an antagonist to the abusable drug substance. The porous material adjoins the antagonist reservoir and is in fluid communication with the skin-contacting surface defined by the active agent component. In one embodiment, the device comprises a barrier layer interposed between the active agent component and the antagonist reservoir.

Abstract: A stable composition of a drug comprising a carrier having a phosphatidylcholine component which entraps the drug is applied to the skin for transdermal delivery of the drug.

Abstract: A polymer blend is prepared by dissolving chitosan and a second polymer in an acidic aqueous solution to form an aqueous polymer blend, dehydrating said aqueous polymer blend, and recovering said polymer blend. The second polymer may be selected from the group consisting of polyether glycols including polyethylene glycols; cellulose esters including cellulose acetate; poloxamers; polysaccharides including dextran and guar; polyvinylpyrrolidones; polyvinyl alcohols; and mixtures or copolymers thereof. These polymer blends swell in an acidic environment and deswell in a more neutral or basic environment. This technology is valuable for the dispensing of biologically active material or drugs into a surrounding environment, especially the environment as is found in the gastrointestinal tract.

Abstract: Formulations containing a PDE5 inhibitor, a water-soluble diluent, a lubricant, a hydrophilic binder, a disintegrant, and optional microcrystalline cellulose and/or a wetting agent, and their use in treating sexual dysfunction, are disclosed.

Abstract: The invention relates to a solid dosage form which is rapidly disintegrating in aqueous medium. Especially, the invention relates to pharmaceutical, orally ingested solid dosage forms, which are designed to disintegrate rapidly within the mouth, and to analogous veterinary dosage forms. Moreover, the invention relates to a unique process for the manufacture of said solid dosage forms.

Abstract: The present invention relates to a pharmaceutical composition for administration by the nasal route of 17-?-oestradiol and norethisterone.

Abstract: This invention concerns an improved particulate composition for delivering a drug to the pulmonary system. Applicants disclose a method of identifying an optimal form of aerodynamically light particles which are highly dispersible. The particles of the instant invention are made by creating hollow, spherical drug particles (i.e., progenitor particles) that collapse in the process of particle formation, leading to wrinkled, thin-walled drug particles of very low envelope density. Additionally, Applicants have found that such particles are especially optimal for inhaled aerosols when the surface area parameter (?) is greater than 2, optimally greater than 3.

Abstract: The goal of the present invention is to provide substances to prevent diseases by activating inherently possessed functions, for cultured fishes and shellfishes and livestock with tendency of decreased immune function due to densely populated breeding environment, and for humans with tendency of easily lowered immune functions due to complicated social structures and aging. The present invention expresses marked effect in preventing infection and cancer by administrating appropriate dose of swine plasma, swine plasma albumin, peptides isolated from swine plasma and swine plasma albumin, and swine plasma mixture, among others including fine powder of Crustacea (including crust of Crustacea), to activate immune function of Crustacea, Pisces, Aves, Mammals, and humans.

Abstract: The invention relates to the use of an extract of olive leaves (Olea europaea) which is titrated in oleanolic acid and which may or may not be associated with a Larrea divaricata extract which is titrated in nordihydroguaiaretic acid (NDGA). Said products are intended for all types of cosmetic and dermopharmaceutical compositions for all forms of skin care, for moisturizing and anti-inflammatory purposes and, in particular, for the prevention and treatment of skin prone to acne.

Abstract: A nutraceutical composition containing xanthones for oral ingestion is disclosed. The composition is a rapidly dissolving film comprising water soluble polymers and xanthones. The xanthones are, preferably, derived from natural plant sources, especially from fruit of Garcinia mangostana L. plant.

Abstract: A composition containing sporopollenin is disclosed which is characterized in that it is present as a solution and, aside from 0.01% to 12% by weight, preferably 0.1% to 5% by weight, of sporopollenin, it also contains 0.01% to 17% by weight, preferably 0.1% to 10% by weight, of at least one emulsifier, it also contains 71.00% to 99.98% by weight, preferably 85% to 99.80% by weight, of at least one hydrophilic solvent, and the use of this composition for cosmetic, pharmaceutical purposes, as chelating agents and nutritional supplements is also disclosed.

Abstract: In the processing of poultry, equipment, instruments, apparatus and/or water used in such processing, and/or carcasses and/or parts of poultry resulting from the processing of poultry, are disinfected with aqueous solutions of certain halogen-based microbiocides, especially certain bromine-based microbiocides. Described are the particular microbiocides used and the substantial advantages of using such materials, in some cases as concentrated solutions and in other cases as dilute solutions.

Abstract: A method for sterilizing canned ackee using an acidic brine solution placed into a container holding either whole or diced ackee arils and heating the container and ackee arils within to a temperature not to exceed the boiling point of water.

Abstract: A composition containing psyllium fiber and xylitol. The composition is in one of powered, liquid or product form. In powdered form the composition is used for producing confectionery products, beverages, baked good products, bakery products, snack bars and similar foodstuff products. In product form, the composition is used to produce confectionery products, baked good products, bakery products, snack bars and similar foodstuff products. The fiber is preferably psyllium fiber. However, the psyllium fiber may be substituted with fruit fiber and derivatives including pectin; seaweed gums and derivatives, including carrageenan, agar and alginates; cellulose and derivatives; cereal grain fibers, including corn, wheat, oat, rice, barley and soy; fructooligosaccharides and its derivatives; seed gums, including guar and locust bean; tree gums, including karaya, tragacanth and acacia; xantham gum; vegetable fiber, including pea and legumes; and potato fiber.

Abstract: A method and system for the reclamation and re-use of rework dough created in the process of forming a final good. Initially, the reworks are formed into a batter into which a catalyst is placed. Subsequently the batter is cooled and stored until it is added to a new batch of dough. Through this method and system there may be a nearly total re-use of rework dough.